Pulmonary atresia: Infants diagnosed prenatally and postnatally have similar outcomes



Prenatal diagnosis of pulmonary atresia is linked to improved oxygenation, but infants diagnosed with this condition postnatally will do just as well if they are identified and treated early, according to a new study in the May issue of the Archives of Disease in Childhood - Fetal and Neonatal Edition.

Aphrodite Tzifa, MD, of Guy's and St. Thomas' Hospital in London, UK, and colleagues sought to determine whether prenatal diagnosis of pulmonary atresia has any bearing on the clinical presentation and neonatal outcome among 37 newborns who received a prenatal diagnosis of pulmonary atresia and 21 who received their diagnosis after birth.

Infants diagnosed with pulmonary atresia postnatally were more hypoxic at birth than their counterparts diagnosed while in utero. Infants diagnosed postnatally presented on day 1 and prostaglandin E therapy was initiated within a median of 3 hours. As a result of such prompt diagnosis and treatment, postnatal diagnosis was not related to greater neonatal morbidity and mortality.

Tzifa A, Barker C, Tibby SM, et al. Prenatal diagnosis of pulmonary atresia: impact on clinical presentation and early outcome. Arch Dis Child- Fetal and Neonatal Edition. 2007;92:F199-F203.

Recent Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.